About VENTOUX BIOSCIENCES INC
Ventoux Biosciences is pioneering therapies for immune-fibrotic diseases through precision science and strategic execution, with a lead program, VEN-201, advancing through preclinical development for Dupuytren’s disease and Spinal Cord Injury.
AI-guided, multi-omic analysis for target identificationPreclinical development of VEN-201 for Dupuytren’s disease and Spinal Cord InjuryTranslational pipeline bridging preclinical validation to human tissue studiesExpertise in immune-fibrotic modulation
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VENTOUX BIOSCIENCES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.